Dr. David Brabham
Claim this profilePharmaTex Research
Studies Cardiovascular Disease
Studies Atherosclerosis
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials David Brabham is currently running
Pelacarsen
for Cardiovascular Disease
Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) 80 mg s.c. QM compared with placebo s.c. QM in US Black/African American and Hispanic participants with established ASCVD and elevated levels of Lp(a) who are treated for cardiovascular (CV) risk factors according to local practice/guidelines for the reduction of cardiovascular risk.
Recruiting1 award Phase 31 criteria
Lepodisiran
for Cardiovascular Disease
This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.
Recruiting1 award Phase 3
More about David Brabham
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David Brabham has experience with
- LY3540378
- Placebo
- Lepodisiran
- Pelacarsen (TQJ230)
Breakdown of trials David Brabham has run
Cardiovascular Disease
Heart Failure
Elevated Lipoprotein
High cholesterol
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Brabham specialize in?
David Brabham focuses on Cardiovascular Disease and Atherosclerosis. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is David Brabham currently recruiting for clinical trials?
Yes, David Brabham is currently recruiting for 3 clinical trials in Amarillo Texas. If you're interested in participating, you should apply.
Are there any treatments that David Brabham has studied deeply?
Yes, David Brabham has studied treatments such as LY3540378, Placebo, Lepodisiran.
What is the best way to schedule an appointment with David Brabham?
Apply for one of the trials that David Brabham is conducting.
What is the office address of David Brabham?
The office of David Brabham is located at: PharmaTex Research, Amarillo, Texas 79109 United States. This is the address for their practice at the PharmaTex Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.